Cuvenax 35 micrograms / pulse

Cuvenax 35 micrograms / pulse

This medicine belongs to the group called Sympathomimetics. It is a medicine that contains oxymetazoline as an active substance that is a nasal decongestant. When administered in the nose, it causes decongestion and improvement of nasal ventilation.

This medicine is indicated for the symptomatic local relief of nasal congestion as in the case of colds and rhinitis.

For adults and children over 6 years.

CN 663822.4

Contact

Fill out the form below and we will respond as soon as possible

I accept the terms and conditions set forth in our privacy policy.
We inform you that PHARMEX uses the data obtained from the contact forms to resolve your queries, as well as to send information that can be considered of a commercial nature. The information that PHARMEX sends refers to what may be of interest to the recipient and at all times is related to PHARMEX products or services and for which the holder has shown some interest.

The legal basis for legality in the processing of data for this purpose is your consent to the consultation, as well as the legitimate interest of PHARMEX for the sending of information that could be considered commercial. Said legitimate interest is weighed by keeping you informed at all times of the possibility of unsubscribing from these shipments and by sending information always related to PHARMEX products and services, about which the holder was interested. These data will not be transferred in any case to third parties.

PHARMEX will keep your data as long as you do not object to its treatment.

Pharmacovigilance Unit

To report an adverse event or complaint contact farmacovigilancia@pharmex.es or call: +34 689 009 866 including, in addition to full details of the adverse reaction, the following information:

– Patient details: Age, sex and country of occurrence.

– Details of the reporting person: Name, address, telephone/email, profession and date.

By sending your notification to farmacovigilancia@pharmex.es you expressly agree that your data will be the responsibility of Pharmex. Your data will be used to analyze your case, follow up, notify the health authorities, and resolve your query. Your data will remain in Pharmex files until the resolution of the case and/or consultation.
You can exercise your rights of access, rectification, deletion, opposition, limitation of processing and portability.
For more information about the treatment of your data, please access Pharmex's privacy policy.

Contact

Fill out the form below and we will respond as soon as possible

PHARMEX will keep your data as long as you do not object to its treatment.

Pharmacovigilance Unit

To report an adverse event or complaint contact farmacovigilancia@pharmex.es or call: +34 689 009 866 including, in addition to full details of the adverse reaction, the following information:

– Patient details: Age, sex and country of occurrence.

– Details of the reporting person: Name, address, telephone/email, profession and date.

Contact

Pharmacovigilance Unit

Contact

Pharmacovigilance Unit

Pages

Archives

Categories

MADRID

MADRID

CÓRDOBA

CÓRDOBA